Riskpilot← Back to searchSign inGet full accessNordic Hormone Concepts ApS
APSActiveCVR 43969137Amaliegade 4, 3.Day spa, sauna and steam bath activities · NACE 9623Est. 2023— employees
Revenue 2025
DKK 11K
EBITDA margin
100.0%
+254% vs 2024
Equity ratio
-176.6%
Financial strength
Net profit 2025
DKK -58K
-741% vs 2024
| Revenue | DKK 11K | — |
| EBITDA | DKK 11K | +254% |
| Net profit | DKK -58K | -741% |
| Total assets | DKK 14K | -65% |
| Equity | DKK -25K | -176% |
| Employees | — | — |
Legal name
Nordic Hormone Concepts ApS
CVR number
43969137
Legal form
Anpartsselskab
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
31. marts 2023
Share capital
DKK 53.061
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede direktion
Company purpose
Selskabets formål er at levere klinisk ledede sundhedsydelser med fokus på hormonel og metabolisk sundhed gennem hele livsforløbet, herunder lægekonsultationer, klinisk vurdering, laboratorietest og gennemgang af biomarkører, behandlingsplanlægning og medicinsk opfølgning (herunder ordination, hvor det er lovligt tilladt), herunder, men ikke begrænset til, perimenopause/menopause, andropause og relaterede livsfaseovergange, samt at drive enhver virksomhed, der er tilknyttet eller forbundet hermed..
Address
Amaliegade 4, 3.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | — | 11 |
| Staff expenses | -0 | -0 |
| EBITDA | -7 | 11 |
| Depreciation & amort. | -0 | -0 |
| EBIT | -7 | 11 |
| Net financials | 0 | -68 |
| Profit before tax | -7 | -57 |
| Tax | -0 | 1 |
| Net profit | -7 | -58 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 41 | 14 |
| Equity | 33 | -25 |
| Long-term debt | 0 | 0 |
| Short-term debt | 8 | 39 |
| Total debt | 8 | 39 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20242025
Equity ratio
-176.6%
This company
38.2%
Market median
-562% vs market
20242025
Return on equity
-5815500.0%
This company
18.4%
Market median
-31606078% vs market
20242025
Net profit margin
-522.4%
This company
8.1%
Market median
-6549% vs market
20242025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20242025
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20242025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-03-31 – 2024-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CT Management | Management | 2026 | — | — |
JA Management | Management | 2026 | — | — |
TT Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
TINE HERTZ HOLDING ApS | Company | 66.7% | 66.7% | 2026 |
Nordic Nexus Group ApS | Company | 20.0% | 20.0% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TINE HERTZ HOLDING ApS
Nordic Hormone Concepts ApS Board members of Nordic Hormone Concepts ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Troels Hansen | Management | 0 companies |
| Jason Alexander Caldwell Blauvelt | Management | 0 companies |
| Tine Terese Hertz | Chief Executive Officer | 0 companies |